Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
61.8M
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
15.7M
-
Shares change
-
+2.04M
-
Total reported value, excl. options
-
$223M
-
Value change
-
+$28.9M
-
Number of buys
-
33
-
Number of sells
-
-4
-
Price
-
$14.17
Significant Holders of Aura Biosciences, Inc. - Common Stock (AURA) as of Q2 2022
41 filings reported holding AURA - Aura Biosciences, Inc. - Common Stock as of Q2 2022.
Aura Biosciences, Inc. - Common Stock (AURA) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.7M shares
of 61.8M outstanding shares and own 25.48% of the company stock.
Largest 10 shareholders include Matrix Capital Management Company, LP (4.11M shares), Medicxi Ventures Management (Jersey) Ltd (3.04M shares), CITADEL ADVISORS LLC (2.31M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.28M shares), Rock Springs Capital Management LP (1.01M shares), BlackRock Inc. (887K shares), FMR LLC (603K shares), VANGUARD GROUP INC (435K shares), Nantahala Capital Management, LLC (343K shares), and STATE STREET CORP (257K shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.